Showing results (481-490 of 5,696) with videos related to
Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|February 19, 1998
The role of interferon as maintenance therapy in malignant lymphomaA AvilésMedical Oncology (Northwood, London, England)|April 30, 2015
Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancerJianhua Lu, Qian Dong, Bingtai Zhang, et al.Medical Oncology (Northwood, London, England)|April 30, 2015
Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junctionHidetaka Sugihara, Takatsugu Ishimoto, Tadahito Yasuda, et al.Medical Oncology (Northwood, London, England)|August 26, 2025
A novel long non-coding RNA, PICSAR, promotes thyroid cancer progression through the hsa-miR-320A/hsa-miR-485/RAPGEFL1 axisMaryam Hejazi, Tahmineh Jafari, AmirHossein Yari, et al.Medical Oncology (Northwood, London, England)|August 26, 2025
Water-based propolis enhances 5-fluorouracil drug efficiency in gastric and colorectal cancer cells through cell stress response, anti-migratory, and apoptotic effects regardless of p53 statusMuhsin Attila Göksoy, Yunus Aksüt, Aslıhan Şengelen, et al.Medical Oncology (Northwood, London, England)|August 27, 2025
The role of phosphatidylcholine metabolism in tumorsLulu Li, Yongxiu Huang, Yaoqi Gui, et al.Medical Oncology (Northwood, London, England)|August 24, 2025
Female and male hormonal-dependent malignancies: the role of long non-coding RNAsYahia Elgharib, Karim Medhat, Fayrouz Fouad, et al.Medical Oncology (Northwood, London, England)|July 25, 2016
Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicineAlphy Rose-James, R Shiji, P Kusumakumary, et al.Medical Oncology (Northwood, London, England)|May 14, 2015
Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapyOleg Gladkov, Vladimir Moiseyenko, Igor N Bondarenko, et al.Medical Oncology (Northwood, London, England)|July 15, 2015
A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancerZhefeng Liu, Zhimin Wei, Yi Hu, et al.Pageof 570